Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 15637147)

1.

The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axis.

Yang WS, Chadalapaka G, Cho SG, Lee SO, Jin UH, Jutooru I, Choi K, Leung YK, Ho SM, Safe S, Kim K.

Neoplasia. 2014 Dec;16(12):1059-69. doi: 10.1016/j.neo.2014.09.011.

2.

Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.

Miyata K, Yotsumoto F, Nam SO, Odawara T, Manabe S, Ishikawa T, Itamochi H, Kigawa J, Takada S, Asahara H, Kuroki M, Miyamoto S.

Cancer Med. 2014 Oct;3(5):1159-69. doi: 10.1002/cam4.301. Epub 2014 Jul 24.

3.

Biosensors in clinical practice: focus on oncohematology.

Fracchiolla NS, Artuso S, Cortelezzi A.

Sensors (Basel). 2013 May 14;13(5):6423-47. doi: 10.3390/s130506423. Review.

4.

Coexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cell.

Bhar A, Haubrock M, Mukhopadhyay A, Maulik U, Bandyopadhyay S, Wingender E.

Algorithms Mol Biol. 2013 Mar 23;8(1):9. doi: 10.1186/1748-7188-8-9.

5.

The role of Transposable Elements in shaping the combinatorial interaction of Transcription Factors.

Testori A, Caizzi L, Cutrupi S, Friard O, De Bortoli M, Cora' D, Caselle M.

BMC Genomics. 2012 Aug 16;13:400. doi: 10.1186/1471-2164-13-400.

6.

Sp1 facilitates DNA double-strand break repair through a nontranscriptional mechanism.

Beishline K, Kelly CM, Olofsson BA, Koduri S, Emrich J, Greenberg RA, Azizkhan-Clifford J.

Mol Cell Biol. 2012 Sep;32(18):3790-9. doi: 10.1128/MCB.00049-12. Epub 2012 Jul 23.

7.

Dynamic network of transcription and pathway crosstalk to reveal molecular mechanism of MGd-treated human lung cancer cells.

Shao L, Wang L, Wei Z, Xiong Y, Wang Y, Tang K, Li Y, Feng G, Xing Q, He L.

PLoS One. 2012;7(5):e31984. doi: 10.1371/journal.pone.0031984. Epub 2012 May 31.

8.

Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells.

Marconett CN, Sundar SN, Tseng M, Tin AS, Tran KQ, Mahuron KM, Bjeldanes LF, Firestone GL.

Carcinogenesis. 2011 Sep;32(9):1315-23. doi: 10.1093/carcin/bgr116. Epub 2011 Jun 21.

9.

Complex formation and interactions between transcription factors essential for human prolactin receptor gene transcription.

Kang JH, Tsai-Morris CH, Dufau ML.

Mol Cell Biol. 2011 Aug;31(16):3208-22. doi: 10.1128/MCB.05337-11. Epub 2011 Jun 13.

10.

MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells.

Kim K, Burghardt R, Barhoumi R, Lee SO, Liu X, Safe S.

J Mol Endocrinol. 2011 Feb 15;46(2):67-79. doi: 10.1677/JME-10-0110. Print 2011 Apr.

11.

The tri-nucleotide spacer sequence between estrogen response element half-sites is conserved and modulates ERalpha-mediated transcriptional responses.

Shu FJ, Sidell N, Yang D, Kallen CB.

J Steroid Biochem Mol Biol. 2010 Jun;120(4-5):172-9. doi: 10.1016/j.jsbmb.2010.04.009. Epub 2010 Apr 18.

12.

Location analysis for the estrogen receptor-alpha reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements.

Mason CE, Shu FJ, Wang C, Session RM, Kallen RG, Sidell N, Yu T, Liu MH, Cheung E, Kallen CB.

Nucleic Acids Res. 2010 Apr;38(7):2355-68. doi: 10.1093/nar/gkp1188. Epub 2010 Jan 4.

13.

A role for the androgen metabolite, 5alpha-androstane-3beta,17beta-diol, in modulating oestrogen receptor beta-mediated regulation of hormonal stress reactivity.

Handa RJ, Weiser MJ, Zuloaga DG.

J Neuroendocrinol. 2009 Mar;21(4):351-8. doi: 10.1111/j.1365-2826.2009.01840.x. Review.

14.

Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

Safe S, Kim K.

J Mol Endocrinol. 2008 Nov;41(5):263-75. doi: 10.1677/JME-08-0103. Epub 2008 Sep 4. Review. Erratum in: J Mol Endocrinol. 2009 Apr;42(4):359. Kim, Kyoungkim [corrected to Kim, Kyounghyun].

15.

In vivo profiling of estrogen receptor/specificity protein-dependent transactivation.

Wu F, Xu R, Kim K, Martin J, Safe S.

Endocrinology. 2008 Nov;149(11):5696-705. doi: 10.1210/en.2008-0720. Epub 2008 Jul 17.

16.

Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain.

Hawse JR, Subramaniam M, Monroe DG, Hemmingsen AH, Ingle JN, Khosla S, Oursler MJ, Spelsberg TC.

Mol Endocrinol. 2008 Jul;22(7):1579-95. doi: 10.1210/me.2007-0253. Epub 2008 May 15.

17.

Ligand structure-dependent activation of estrogen receptor alpha/Sp by estrogens and xenoestrogens.

Wu F, Khan S, Wu Q, Barhoumi R, Burghardt R, Safe S.

J Steroid Biochem Mol Biol. 2008 May;110(1-2):104-15. doi: 10.1016/j.jsbmb.2008.02.008. Epub 2008 Feb 23.

18.
19.

Visualizing the action of steroid hormone receptors in living cells.

Griekspoor A, Zwart W, Neefjes J, Michalides R.

Nucl Recept Signal. 2007 Mar 9;5:e003. Review.

20.

A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.

Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M.

Genes Dev. 2006 Sep 15;20(18):2513-26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk